News & Updates

International Society of Pediatric Oncology (SIOP) Moves Congress Online

August 3, 2020 CAC2 Community News No comments yet

On behalf of the International Society of Paediatric Oncology (SIOP), please note that SIOP 2020 will take place as a virtual congress on the same dates: October 14-17, 2020. Additionally, Late-Breaking Abstract Submission is open until August 26, allowing everyone to share their research from wherever they are based. […]

Childhood Cancer and Prevention – The Time is Now

July 29, 2020 CAC2 Survivorship Matters Blog No comments yet

Survivorship Matters Blog By CAC2 Member Mary Beth Collins My introduction to the idea of prevention and childhood cancer didn’t come from a yearning for advocacy and systems change. It also didn’t come years after my son was diagnosed, with a desire to help other parents learn how to nurture [...]

Joining Forces to Bring New Therapies to Children with Cancer

July 26, 2020 CAC2 Collaborative Achievements, Member Blogs No comments yet

By Guest Blogger, CAC2 Member Cesare Spadoni (aPODD). “Pharma and biotech companies do not develop drugs for kids with cancer!” How many times have we heard these words within the childhood cancer community? Over the past several decades we have witnessed unprecedented progress in oncology, with an array of [...]

CAC2 2020 Annual Summit

July 16, 2020 CAC2 CAC2 News No comments yet

Over 100 CAC2 members and guests gathered for a special online event on Friday, July 17, 2020 to attend our 8th Annual Summit Speaker Program and Annual Members' Business Meeting. Our volunteer Meetings Team designed a carefully curated two-hour version of our traditional Annual Summit accessible to all. Dr. [...]

Update on Federal Childhood Cancer Appropriations Process

July 15, 2020 CAC2 Community News No comments yet

Update from our colleagues at the Alliance for Childhood Cancer (July 13, 2020): The House Appropriations Committee agreed to fully fund the Childhood Cancer STAR Act and the Childhood Cancer Data Initiative again this year. Notably, the Senate has historically championed our cause for STAR funding, so this development in [...]

New Report to be Released: Cross-Sector Strategies for Childhood Cancer Prevention

July 11, 2020 CAC2 Member Blogs No comments yet

By Guest Blogger, CAC2 Member Jonathan Agin (Max Cure Foundation) I frequently speak of viewing childhood cancer like a bicycle wheel with multiple spokes emanating from the hub in the center. Each spoke represents a problem or area of focus: drug development, psychosocial care, early detection, survivorship, research funding, access to treatment, [...]

Five Categories of Childhood and Adolescent Cancer Survivorship

July 1, 2020 CAC2 Curated Research Library No comments yet

The CAC2 Survivorship Working Group assembled this document to help categorize survivorship issues for the community. It is by no means an exhaustive list, but it gives examples of some of the challenges that survivors face in each of the categories that our group has identified. EDUCATIONAL: Academic Success – […]

The Art and Science of Navigating the Clinical Trials Landscape for Childhood Cancer

June 18, 2020 CAC2 Webinars No comments yet

Our June CAC2 All-Member webinar explored the world of clinical trials and helped us understand the important role of clinical trial navigation, a topic that is growing in importance as the number and variety of options for pediatric and adolescent oncology patients has begun to grow. Brenna Carswell, Clinical Trials Navigator [...]

FDA Approves Gemtuzumab Ozogamicin for CD33-Positive AML in Pediatric Patients

June 16, 2020 CAC2 Community News No comments yet

On June 16, 2020, the Food and Drug Administration extended the indication of gemtuzumab ozogamicin (MYLOTARGTM, Wyeth Pharmaceuticals LLC) for newly-diagnosed CD33-positive acute myeloid leukemia (AML) to include pediatric patients 1 month and older. Read More Here On June 16, 2020, the Food and Drug Administration granted accelerated approval [...]

AACR Sponsored Listening Session with FDA

May 27, 2020 CAC2 Community News No comments yet

The American Association for Cancer Research (AACR) and the U.S. Food and Drug Administration (FDA) recorded a listening session on May 27, 2020 for patient advocates to learn more about cancer clinical trials during COVID-19. The session is about 45 minutes, with the pediatric questions at about minute 25.5, minute […]